Market closed

PTC Therapeutics/$PTCT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About PTC Therapeutics

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

Ticker

$PTCT
Trading on

Industry

Biotechnology

Employees

939

PTC Therapeutics Metrics

BasicAdvanced
$3.9B
-
-$4.73
0.66
-
$3.9B
0.66
$58.38
$24.00
1.1M
2.35
2.258
-200.341
-225.038
-0.86%
-5.09%
37.91%
4.72
-3.51
-2.96
-20.929
-13.97%
-43.54%
14.42%
-14.01%

What the Analysts think about PTC Therapeutics

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for PTC Therapeutics stock.

PTC Therapeutics Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PTC Therapeutics Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PTCT

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for PTC Therapeutics stock?

PTC Therapeutics (PTCT) has a market cap of $3.9B as of April 25, 2025.

What is the P/E ratio for PTC Therapeutics stock?

The price to earnings (P/E) ratio for PTC Therapeutics (PTCT) stock is 0 as of April 25, 2025.

Does PTC Therapeutics stock pay dividends?

No, PTC Therapeutics (PTCT) stock does not pay dividends to its shareholders as of April 25, 2025.

When is the next PTC Therapeutics dividend payment date?

PTC Therapeutics (PTCT) stock does not pay dividends to its shareholders.

What is the beta indicator for PTC Therapeutics?

PTC Therapeutics (PTCT) has a beta rating of 0.66. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.